7 Organisations

Industry Associations & Lobby Groups

Industry representatives and professional lobbyists working to shape psychedelic legislation and regulation.

Policy Advocacy

Where they work, what they do, who they serve

Compare organizations by country coverage, audience, and advocacy activity. Activity tags describe the organization overall unless the profile has country-specific project evidence.

organisations

countries

activities

Showing 7 of 7 organisations

All organisations

7 orgs

Organisation	Audience	Activities	Countries	Profile
American Psychiatric Association Industry Associations & Lobby Groups	Patients & familiesClinicians+3	Policy Briefing and ConsultationRegulatory Comment Submissions+2 Research and Evidence Policy BriefingHealth System Implementation Policy+3 Org-level	United States	Profile
International Alliance of MDMA Practitioners (MDMA Alliance) Industry Associations & Lobby Groups	Patients & familiesClinicians+4	Coalition BuildingPolicy Briefing and Consultation+2 Medical Access PathwaysHealth System Implementation Policy+2 Org-level	Cross-country	Profile
MAPS Caucuses & Working Groups	Patients & familiesClinicians+4	Legislative AdvocacyPublic Education Campaigning+4 Medical Access PathwaysControlled Substance / Scheduling Reform+5 Org-level	United States	Profile
Psychedelic Coalition for Health Industry Associations & Lobby Groups	CliniciansAdvocates & community organizations+4	Public Education CampaigningPolicy Briefing and Consultation+2 Medical Access PathwaysHealth System Implementation Policy+3 Org-level	United States	Profile
Psychedelic Medicine Coalition Ballot Initiatives & Policy Change Campaigns	Patients & familiesVeterans & first responders+5	Legislative AdvocacyPolicy Briefing and Consultation+2 Medical Access PathwaysControlled Substance / Scheduling Reform+4 Org-level	United States	Profile
Psychedelic Medicine PAC Industry Associations & Lobby Groups	Patients & familiesVeterans & first responders+5	Legislative AdvocacyPublic Education Campaigning+2 Medical Access PathwaysControlled Substance / Scheduling Reform+3 Org-level	United States	Profile
PsychedelicsEUROPE Caucuses & Working Groups	Patients & familiesClinicians+5	Legislative AdvocacyPolicy Briefing and Consultation+1 Medical Access PathwaysControlled Substance / Scheduling Reform+3 Org-level	Cross-country	Profile